SAREPTA THERAPEUTICS Trademark

Trademark Overview

On Tuesday, June 5, 2012, a trademark application was filed for SAREPTA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SAREPTA THERAPEUTICS trademark a serial number of 85643841. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Tuesday, June 1, 2021. This trademark is owned by AVI BioPharma, Inc.. The SAREPTA THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceuticals and pharmaceutical products for treating muscular dystrophy ((, infectious diseases and viruses that respond to ribonucleic acid (RNA)-based therapies )) ; pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression

medical and scientific research services, namely, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies
sarepta therapeutics

General Information

Serial Number85643841
Word MarkSAREPTA THERAPEUTICS
Filing DateTuesday, June 5, 2012
Status701 - SECTION 8 - ACCEPTED
Status DateTuesday, June 1, 2021
Registration Number4653265
Registration DateTuesday, December 9, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2013

Trademark Statements

Goods and Servicespharmaceuticals and pharmaceutical products for treating muscular dystrophy ((, infectious diseases and viruses that respond to ribonucleic acid (RNA)-based therapies )) ; pharmaceuticals comprising drugs based on Phosphorodiamidate Morpholino Oligomers technology platform, and drugs that modulate RNA expression
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and Servicesmedical and scientific research services, namely, medical research; medical and scientific research services all in the field of muscular dystrophy, infectious diseases and viruses that respond to ribonucleic acid (RNA) modulation therapies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 14, 2012
Primary Code005
First Use Anywhere DateThursday, July 12, 2012
First Use In Commerce DateWednesday, October 15, 2014
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 14, 2012
Primary Code042
First Use Anywhere DateThursday, July 12, 2012
First Use In Commerce DateWednesday, October 15, 2014

Trademark Owner History

Party NameSAREPTA THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameSAREPTA THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02142
Party NameSAREPTA THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameSAREPTA THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBOTHELL, WA 98021
Party NameAVI BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBothell, WA 98021

Trademark Events

Event DateEvent Description
Saturday, December 9, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, June 1, 2021SEC. 15 ACKNOWLEDGEMENT - E-MAILED
Tuesday, June 1, 2021NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, June 1, 2021REGISTERED - SEC. 15 ACKNOWLEDGED
Tuesday, June 1, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, June 1, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 16, 2020TEAS SECTION 15 RECEIVED
Monday, November 16, 2020TEAS SECTION 8 RECEIVED
Monday, December 9, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, March 2, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 18, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 18, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 9, 2014REGISTERED-PRINCIPAL REGISTER
Friday, November 7, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, November 6, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 23, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 22, 2014STATEMENT OF USE PROCESSING COMPLETE
Wednesday, October 15, 2014USE AMENDMENT FILED
Wednesday, October 22, 2014SOU EXTENSION 3 GRANTED
Wednesday, October 15, 2014SOU EXTENSION 3 FILED
Wednesday, October 15, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, October 15, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, April 29, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 28, 2014SOU EXTENSION 2 GRANTED
Wednesday, April 16, 2014SOU EXTENSION 2 FILED
Wednesday, April 16, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, November 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2013SOU EXTENSION 1 GRANTED
Thursday, October 10, 2013SOU EXTENSION 1 FILED
Tuesday, November 12, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 10, 2013SOU TEAS EXTENSION RECEIVED
Wednesday, September 18, 2013AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, September 16, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 16, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 30, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 5, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 30, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 29, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, January 29, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 29, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, January 29, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, January 28, 2013PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sunday, January 27, 2013WITHDRAWN FROM PUB - OG REVIEW QUERY
Saturday, January 12, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, January 11, 2013ASSIGNED TO LIE
Monday, December 24, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 20, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 19, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 19, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 18, 2012AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 2, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 2, 2012NON-FINAL ACTION E-MAILED
Monday, July 2, 2012NON-FINAL ACTION WRITTEN
Wednesday, June 27, 2012ASSIGNED TO EXAMINER
Thursday, June 14, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 8, 2012NEW APPLICATION ENTERED

Related Keywords

therapeutics sarepta research medical therapies based pharmaceuticals services scientific acid drugs ribonucleic